IQ-AI Regulatory News (IQAI)

IQ-AI Information

There is currently no data for IQAI

REMOVE ADS

Offer Talks Terminated

21 Nov 2008 07:10

RNS Number : 6336I

Flying Brands Limited

21 November 2008

Flying Brands Limited ("Flying Brands" or the "Company")

21 November 2008

Termination of Offer Period

Following West Coast Capital's announcement earlier today that it has been unable to reach agreement with the Board of Flying Brands (the "Board") on the terms of a recommended bid for the Company, the Board confirms that it is no longer in talks with West Coast Capital or any other party regarding an offer for the Company. Accordingly Flying Brands is no longer in an Offer Period for the purposes of the Takeover Code.

Contact

Flying Brands Limited

Tim Trotter

0844 884 6465

End

This information is provided by RNS

The company news service from the London Stock Exchange

END

OTTEAXFEADDPFFE

Date		Source	Headline
18th Aug 2023	11:20 am	RNS	IB & GE HealthCare Enter into Commercial Agreement
17th Aug 2023	7:00 am	RNS	Half-year Report
19th Jul 2023	7:00 am	RNS	Imaging Biometrics Installs IB Nimble™ For MCW
13th Jul 2023	7:00 am	RNS	Orphan Drug Designation for GaM in Pediatric GBM
27th Jun 2023	7:00 am	RNS	Studies Show GaM Inhibits Pediatric Tumor Growth
23rd May 2023	11:02 am	RNS	Result of AGM
23rd May 2023	7:00 am	RNS	AGM Statement
3rd May 2023	4:14 pm	RNS	Notice of AGM
26th Apr 2023	7:00 am	RNS	Final Results
28th Feb 2023	3:52 pm	RNS	Orphan Drug Designation Status
13th Jan 2023	2:05 pm	RNS	Second Price Monitoring Extn
13th Jan 2023	2:00 pm	RNS	Price Monitoring Extension
13th Jan 2023	11:05 am	RNS	Second Price Monitoring Extn
13th Jan 2023	11:00 am	RNS	Price Monitoring Extension
10th Jan 2023	7:00 am	RNS	Letter to Shareholders
2nd Dec 2022	11:11 am	RNS	Holding in Company
25th Oct 2022	11:00 am	RNS	Price Monitoring Extension
30th Sep 2022	7:00 am	RNS	Letter to Shareholders
26th Sep 2022	7:00 am	RNS	Issue of Warrants to Employees
16th Aug 2022	4:40 pm	RNS	Second Price Monitoring Extn
16th Aug 2022	4:35 pm	RNS	Price Monitoring Extension
16th Aug 2022	9:28 am	RNS	Half-year Report
3rd Aug 2022	1:01 pm	RNS	TR1 - Notification of Major Holdings
11th Jul 2022	7:00 am	RNS	Imaging Biometrics Announces Channel Partnership
31st May 2022	11:05 am	RNS	Second Price Monitoring Extn
31st May 2022	11:00 am	RNS	Price Monitoring Extension
31st May 2022	8:00 am	RNS	Submission of FDA 510(k) Application for IB Zero G
30th May 2022	10:47 am	RNS	Result of AGM
5th May 2022	3:00 pm	RNS	Notice of AGM
3rd May 2022	2:21 pm	RNS	IB Broadens Quantitative Mapping
28th Apr 2022	5:52 pm	RNS	Final Results
9th Mar 2022	3:08 pm	RNS	IQAI’s Sponsored Phase I Clinical Trial is Open
28th Feb 2022	11:12 am	RNS	Total Voting Rights
8th Feb 2022	7:00 am	RNS	Issue of shares to Mayo Clinic
27th Jan 2022	7:00 am	RNS	Imaging Biometrics LLC - Letter to Shareholders
4th Jan 2022	9:27 am	RNS	Director/PDMR Shareholding
17th Dec 2021	7:37 am	RNS	IQ-AI Prepares for Phase I Clinical Trial Launch
13th Dec 2021	10:32 am	RNS	Director's Interest
11th Nov 2021	8:52 am	RNS	Agreement with St. Jude Children’s Hospital
2nd Nov 2021	8:19 am	RNS	MD ANDERSON ADOPTS IB CLINIC
28th Oct 2021	4:00 pm	RNS	Letter to Shareholders
7th Oct 2021	4:41 pm	RNS	Second Price Monitoring Extn
7th Oct 2021	4:36 pm	RNS	Price Monitoring Extension
7th Oct 2021	2:05 pm	RNS	Second Price Monitoring Extn
7th Oct 2021	2:00 pm	RNS	Price Monitoring Extension
7th Oct 2021	12:00 pm	RNS	Placing
1st Oct 2021	8:17 am	RNS	Case Report on Clinical Value of IB Software
22nd Sep 2021	7:00 am	RNS	EU PATENT FOR DUAL-ECHO MR PERFUSION PROCESSSING
17th Sep 2021	7:00 am	RNS	IB Software Chosen for Accuracy and Automation
10th Sep 2021	7:00 am	RNS	Update on Phase I Clinical Trial

Latest Share Chat

IQ-AI Regulatory News (IQAI)

Offer Talks Terminated

Please enter at least 2 characters

No results found

Search results

Recently viewed

Trending